• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多种骨软骨瘤和软骨肉瘤中硫酸乙酰肝素的结构特征。

Structural Features of Heparan Sulfate from Multiple Osteochondromas and Chondrosarcomas.

机构信息

Istituto di Ricerche Chimiche e Biochimiche G. Ronzoni, V. G. Colombo 81, 20133 Milan, Italy.

IRCCS-Istituto Ortopedico Rizzoli, V. di Barbiano 1/10, 40136 Bologna, Italy.

出版信息

Molecules. 2018 Dec 11;23(12):3277. doi: 10.3390/molecules23123277.

DOI:10.3390/molecules23123277
PMID:30544937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6321082/
Abstract

Multiple osteochondromas (MO) is a hereditary disorder associated with benign cartilaginous tumors, known to be characterized by absence or highly reduced amount of heparan sulfate (HS) in the extracellular matrix of growth plate cartilage, which alters proper signaling networks leading to improper bone growth. Although recent studies demonstrated accumulation of HS in the cytoplasm of MO chondrocytes, nothing is known on the structural alterations which prevent HS from undergoing its physiologic pathway. In this work, osteochondroma (OC), peripheral chondrosarcoma, and healthy cartilaginous human samples were processed following a procedure previously set up to structurally characterize and compare HS from pathologic and physiologic conditions, and to examine the phenotypic differences that arise in the presence of either exostosin 1 or 2 ( or ) mutations. Our data suggest that HS chains from OCs are prevalently below 10 kDa and slightly more sulfated than healthy ones, whereas HS chains from peripheral chondrosarcomas (PCSs) are mostly higher than 10 kDa and remarkably more sulfated than all the other samples. Although deeper investigation is still necessary, the approach here applied pointed out, for the first time, structural differences among OC, PCS, and healthy HS chains extracted from human cartilaginous excisions, and could help in understanding how the structural features of HS are modulated in the presence of pathological situations also involving different tissues.

摘要

多发性骨软骨瘤(MO)是一种与良性软骨肿瘤相关的遗传性疾病,其特征是生长板软骨细胞外基质中缺乏或高度减少肝素硫酸盐(HS),这会改变适当的信号网络,导致骨骼生长异常。尽管最近的研究表明 MO 软骨细胞的细胞质中 HS 的积累,但对于阻止 HS 进行其生理途径的结构改变仍一无所知。在这项工作中,对骨软骨瘤(OC)、外周软骨肉瘤和健康的人类软骨样本进行了处理,采用了先前建立的程序,以对来自病理和生理条件的 HS 进行结构表征和比较,并检查在存在外切聚糖 1 或 2(或)突变时出现的表型差异。我们的数据表明,OC 中的 HS 链主要小于 10 kDa,比健康 HS 链的硫酸化程度略高,而外周软骨肉瘤(PCSs)中的 HS 链主要大于 10 kDa,比所有其他样本的硫酸化程度都高。尽管还需要进一步深入研究,但这里应用的方法首次指出了从人软骨切除物中提取的 OC、PCS 和健康 HS 链之间的结构差异,并有助于理解 HS 的结构特征如何在涉及不同组织的病理情况下发生调节。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3956/6321082/dd1768b8445d/molecules-23-03277-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3956/6321082/786e869cea30/molecules-23-03277-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3956/6321082/5126d7d26b0c/molecules-23-03277-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3956/6321082/2a225a55fd35/molecules-23-03277-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3956/6321082/cb9a16ebfaa2/molecules-23-03277-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3956/6321082/2d4a20297fef/molecules-23-03277-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3956/6321082/f294626ca84e/molecules-23-03277-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3956/6321082/dd1768b8445d/molecules-23-03277-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3956/6321082/786e869cea30/molecules-23-03277-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3956/6321082/5126d7d26b0c/molecules-23-03277-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3956/6321082/2a225a55fd35/molecules-23-03277-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3956/6321082/cb9a16ebfaa2/molecules-23-03277-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3956/6321082/2d4a20297fef/molecules-23-03277-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3956/6321082/f294626ca84e/molecules-23-03277-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3956/6321082/dd1768b8445d/molecules-23-03277-g007.jpg

相似文献

1
Structural Features of Heparan Sulfate from Multiple Osteochondromas and Chondrosarcomas.多种骨软骨瘤和软骨肉瘤中硫酸乙酰肝素的结构特征。
Molecules. 2018 Dec 11;23(12):3277. doi: 10.3390/molecules23123277.
2
Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma.甲状旁腺激素相关蛋白(PTHrP)和Bcl-2表达上调是骨软骨瘤向周围型软骨肉瘤进展的特征,且是中央型软骨肉瘤的晚期事件。
Lab Invest. 2000 Dec;80(12):1925-34. doi: 10.1038/labinvest.3780202.
3
Decreased EXT expression and intracellular accumulation of heparan sulphate proteoglycan in osteochondromas and peripheral chondrosarcomas.骨软骨瘤和外周软骨肉瘤中EXT表达降低及硫酸乙酰肝素蛋白聚糖的细胞内积聚。
J Pathol. 2007 Mar;211(4):399-409. doi: 10.1002/path.2127.
4
Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT.继发于骨软骨瘤的外周性软骨肉瘤,是由于具有功能 EXT 的细胞向外生长而引起的。
Oncogene. 2012 Mar 1;31(9):1095-104. doi: 10.1038/onc.2011.311. Epub 2011 Aug 1.
5
No haploinsufficiency but loss of heterozygosity for EXT in multiple osteochondromas.多发性骨软骨瘤中 EXT 不存在单倍体不足,但存在杂合性丢失。
Am J Pathol. 2010 Oct;177(4):1946-57. doi: 10.2353/ajpath.2010.100296. Epub 2010 Sep 2.
6
The pathogenic roles of heparan sulfate deficiency in hereditary multiple exostoses.硫酸乙酰肝素缺陷在遗传性多发性外生骨疣中的致病作用。
Matrix Biol. 2018 Oct;71-72:28-39. doi: 10.1016/j.matbio.2017.12.011. Epub 2017 Dec 24.
7
Peripheral chondrosarcoma progression is associated with increased type X collagen and vascularisation.外周性软骨肉瘤的进展与 X 型胶原和血管生成的增加有关。
Virchows Arch. 2012 Jan;460(1):95-102. doi: 10.1007/s00428-011-1168-9. Epub 2011 Nov 25.
8
EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas.散发性和遗传性骨软骨瘤及继发性软骨肉瘤中的EXT基因突变分析与杂合性缺失
Am J Hum Genet. 1999 Sep;65(3):689-98. doi: 10.1086/302532.
9
Aberrant heparan sulfate proteoglycan localization, despite normal exostosin, in central chondrosarcoma.在中央型软骨肉瘤中,尽管外生骨疣蛋白正常,但硫酸乙酰肝素蛋白聚糖定位异常。
Am J Pathol. 2009 Mar;174(3):979-88. doi: 10.2353/ajpath.2009.080623. Epub 2009 Jan 29.
10
Osteochondroma formation is independent of heparanase expression as revealed in a mouse model of hereditary multiple exostoses.遗传性多发性外生骨疣小鼠模型表明,骨软骨瘤的形成与乙酰肝素酶表达无关。
J Orthop Res. 2022 Oct;40(10):2391-2401. doi: 10.1002/jor.25260. Epub 2022 Jan 22.

引用本文的文献

1
Heparan Sulfate Proteoglycan Signaling in Tumor Microenvironment.硫酸乙酰肝素蛋白聚糖在肿瘤微环境中的信号转导。
Int J Mol Sci. 2020 Sep 9;21(18):6588. doi: 10.3390/ijms21186588.
2
Introduction to the Molecules Special Edition Entitled '': Some Outstanding Questions in Heparan Sulfate and Heparin Research.分子特刊简介:标题为“硫酸乙酰肝素和肝素研究中的一些突出问题”。
Molecules. 2019 Apr 10;24(7):1399. doi: 10.3390/molecules24071399.

本文引用的文献

1
The pathogenic roles of heparan sulfate deficiency in hereditary multiple exostoses.硫酸乙酰肝素缺陷在遗传性多发性外生骨疣中的致病作用。
Matrix Biol. 2018 Oct;71-72:28-39. doi: 10.1016/j.matbio.2017.12.011. Epub 2017 Dec 24.
2
Heparan sulfate in skeletal development, growth, and pathology: the case of hereditary multiple exostoses.硫酸乙酰肝素在骨骼发育、生长和病理学中的作用:以遗传性多发性外生性骨疣为例。
Dev Dyn. 2013 Sep;242(9):1021-32. doi: 10.1002/dvdy.24010. Epub 2013 Jul 29.
3
Heparan sulfate 6-O-sulfotransferase isoform-dependent regulatory effects of heparin on the activities of various proteases in mast cells and the biosynthesis of 6-O-sulfated heparin.
肝素对肥大细胞中各种蛋白酶活性及 6-O-硫酸肝素生物合成的肝素硫酸盐 6-O-磺基转移酶同工型依赖性调节作用。
J Biol Chem. 2013 Feb 8;288(6):3705-17. doi: 10.1074/jbc.M112.416651. Epub 2012 Dec 6.
4
Cartilage tumour progression is characterized by an increased expression of heparan sulphate 6O-sulphation-modifying enzymes.软骨肿瘤的进展特征是硫酸乙酰肝素 6O-磺化修饰酶的表达增加。
Virchows Arch. 2012 Oct;461(4):475-81. doi: 10.1007/s00428-012-1300-5. Epub 2012 Aug 18.
5
Detection and characterization of syndecan-1-associated heparan sulfate 6-O-sulfated motifs overexpressed in multiple myeloma cells using single chain antibody variable fragments.利用单链抗体可变片段检测和鉴定在多发性骨髓瘤细胞中过表达的与syndecan-1相关的硫酸乙酰肝素6-O-硫酸化基序
Hum Antibodies. 2012;21(1-2):29-40. doi: 10.3233/HAB-2012-0259.
6
Heparin and heparan sulfate: analyzing structure and microheterogeneity.肝素与硫酸乙酰肝素:结构及微观异质性分析
Handb Exp Pharmacol. 2012(207):159-76. doi: 10.1007/978-3-642-23056-1_8.
7
Heparin-like heparan sulfate from rabbit cartilage.兔软骨中肝素样硫酸乙酰肝素。
Glycobiology. 2012 Feb;22(2):248-57. doi: 10.1093/glycob/cwr143. Epub 2011 Sep 20.
8
Heparan sulfate proteoglycans.肝素硫酸蛋白聚糖。
Cold Spring Harb Perspect Biol. 2011 Jul 1;3(7):a004952. doi: 10.1101/cshperspect.a004952.
9
Biosynthesis of heparan sulfate in EXT1-deficient cells.EXT1 缺陷细胞中肝素硫酸的生物合成。
Biochem J. 2010 May 27;428(3):463-71. doi: 10.1042/BJ20100101.
10
Mutation in the heparan sulfate biosynthesis enzyme EXT1 influences growth factor signaling and fibroblast interactions with the extracellular matrix.EXT1 硫酸乙酰肝素生物合成酶突变影响生长因子信号转导和成纤维细胞与细胞外基质的相互作用。
J Biol Chem. 2009 Dec 11;284(50):34935-43. doi: 10.1074/jbc.M109.005264. Epub 2009 Oct 22.